Advertisement

The role of behavioral conditioning in the development of nausea

      Abstract

      Literature related to the prevalence and etiology of anticipatory nausea and vomiting associated with chemotherapy is reviewed. Physiologic causes and psychological factors, including expectations, beliefs, and conditioning, are examined to help explain these phenomena. The efficacy of pharmacologic and behavioral treatments is discussed. Similarities between the experience of anticipatory nausea and vomiting and morning sickness suggest that the conditioning model may be relevant to understanding the development of pregnancy-related nausea. (Am J Obstet Gynecol 2002;186:S239-43.)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bilgrami S
        • Fallon BG.
        Chemotherapy-induced nausea and vomiting. Easing patients' fear and discomfort with effective antiemetic regimens.
        Postgrad Med. 1993; 94: 55-58
        • Roscoe JA
        • Morrow GR
        • Hickok JT
        • Stern RM.
        Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices.
        J Pain Symptom Manage. 2000; 20: 113-121
        • Burish TG
        • Carey MP.
        Conditioned aversive responses in cancer chemotherapy patients: theoretical and developmental analysis.
        J Consult Clin Psychol. 1986; 54: 593-600
        • Abell TL
        • Reily C.
        Hyperemesis gravidarum.
        Gastroenterol Clin N Am. 1992; 21: 835-849
        • Morrow GR
        • Roscoe JA.
        Anticipatory nausea and vomiting: Models, mechanisms and management. Martin Dunitz, London1997: 149-166
        • De la Ronde S.
        Nausea and vomiting in pregnancy.
        J Soc Obstetricians and Gynaecologists Can. 1994; 16: 2035-2041
        • Koch KL
        • Stern RM
        • Vasey M
        • Botti JJ
        • Creasy GW
        • Dwyer A.
        Gastric dysrhythmias and nausea of pregnancy.
        Dig Dis Sci. 1990; 35: 961-968
        • Myles M.
        Textbook for midwives.
        in: Churchill-Livingstone, New York1975: 124
        • Pritchard J
        • Macdonald P.
        Williams' obstetrics.
        in: Appleton-Century-Crofts, New York1980: 322-323
        • Wickham R.
        Managing chemotherapy-related nausea and vomiting: the state of the art.
        Oncol Nurs Forum. 1989; 16: 563-574
        • Kvale G
        • Hugdahl K
        • Asbjornsen A
        • Rosengren B
        • Lote K
        • Nordby H.
        Anticipatory nausea and vomiting in cancer patients.
        J Consult Clin Psychol. 1991; 59: 894-898
        • Gralla RJ
        • Itri LM
        • Pisko SE
        • Squillante AE
        • Kelson DP
        • Braun DW
        • et al.
        Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
        N Engl J Med. 1981; 305: 905-909
        • Morrow GR
        • Roscoe JA
        • Hickok JT.
        Nausea and vomiting.
        in: Holland JC Oxford University Press, New York1998: 476-484
        • Deuchar N.
        Nausea and vomiting in pregnancy: a review of the problem with particular regard to psychological and social aspects.
        Br J Obstet Gynaecol. 1995; 102: 6-8
        • Hyde E.
        Acupressure therapy for morning sickness. A controlled clinical trial.
        J Nurse Midwifery. 1989; 34: 171-178
        • Jacobsen PB
        • Andrykowski MA
        • Redd WH
        • Die-Trill M
        • Hakes TB
        • Kaufman RJ
        • et al.
        Nonpharmacologic factors in the development of posttreatment nausea with adjuvant chemotherapy for breast cancer.
        Cancer. 1988; 61: 379-385
        • Haut MW
        • Beckwith B
        • Laurie JA
        • Klatt N.
        Postchemotherapy nausea and vomiting in cancer patients receiving outpatient chemotherapy.
        J Psychosoc Oncol. 1991; 9: 117-130
        • Rhodes VA
        • Watson PM
        • McDaniel RW
        • Hanson BM
        • Johnson MH.
        Expectation and occurrence of postchemotherapy side effects: nausea and vomiting.
        Cancer Pract. 1995; 3: 247-253
        • Roscoe JA
        • Hickok JT
        • Morrow GR.
        Patient expectations as predictor of chemotherapy-induced nausea.
        Ann Behav Med. 2000; 22: 121-126
        • Andrykowski MA
        • Redd WH
        • Hatfield AK.
        Development of anticipatory nausea: a prospective analysis.
        J Consult Clin Psychol. 1985; 53: 447-454
        • Montgomery GH
        • Bovbjerg DH.
        The development of anticipatory nausea in patients receiving adjuvant chemotherapy for breast cancer.
        Physiol Behav. 1997; 61: 737-741
        • Kvale G
        • Hugdahl K.
        Cardiovascular conditioning and anticipatory nausea and vomiting in cancer patients.
        Behav Med. 1994; 20: 78-173
        • Challis GB
        • Stam HJ.
        A longitudinal study of the development of anticipatory nausea and vomiting in cancer chemotherapy patients: the role of absorption and autonomic perception.
        Health Psychol. 1992; 11: 181-189
        • Fredrikson M
        • Hursti T
        • Salmi P
        • Borjeson S
        • Furst CJ
        • Peterson C
        • et al.
        Conditioned nausea after cancer chemotherapy and autonomic nervous system conditionability.
        Scand J Psychol. 1993; 34: 318-327
        • Carey MP
        • Burish TG.
        Etiology and treatment of the psychological side effects associated with cancer chemotherapy: a critical review and discussion.
        Psychol Bull. 1988; 104: 307-325
        • Morrow GR
        • Lindke J
        • Black PM.
        Predicting development of anticipatory nausea in cancer patients: prospective examination of eight clinical characteristics.
        J Pain Symptom Manage. 1991; 6: 215-223
        • Morrow GR.
        Chemotherapy-related nausea and vomiting: etiology and management.
        Ca Cancer J Clin. 1989; 39: 89-104
        • Andrykowski MA.
        The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: a review and synthesis.
        Psychosom Med. 1990; 52: 458-475
        • Wampler G.
        The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis.
        Drugs. 1983; 25: 35-51
        • Miner WD
        • Sanger GJ.
        Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism.
        Br J Pharmacol. 1986; 88: 497-499
        • Ettinger DS
        • Huber S
        • Kris MG
        • Levy M
        • McNulty R
        • Noonan KR
        • et al.
        NCCN Proceedings. NCCN antiemesis practice guidelines.
        Oncology (Huntingt). 1997; 11: 57-89
        • de Mulder PHM
        • Seynaeve C
        • Vermorken JD
        • van Liessum PA
        • Mols-Jevdevic S
        • Allman EL
        • et al.
        Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
        Ann Intern Med. 1990; 113: 834-840
        • Marty M
        • Pouillart P
        • Scholl S
        • Droz JP
        • Azab M
        • Brion N
        • et al.
        Comparison of the 5-hydroxytryptamine (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.
        New Engl J Med. 1990; 322: 816-821
        • Morrow GR
        • Roscoe JA
        • Hynes HE
        • Flynn PJ
        • Pierce HI
        • Burish T.
        Progress in reducing anticipatory nausea and vomiting: a study of community practice.
        Support Care Cancer. 1998; 6: 46-50
        • Morrow GR
        • Arseneau JC
        • Asbury RF
        • Bennett JM
        • Boros L.
        Anticipatory nausea and vomiting with chemotherapy.
        N Engl J Med. 1982; 306: 431-432
        • Navari RM
        • Kaplan HG
        • Gralla RJ
        • Grunberg SM
        • Palmer R
        • Fitts D.
        Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin.
        J Clin Oncol. 1994; 12: 2204-2210
        • Morrow GR
        • Morrell C.
        Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy.
        N Engl J Med. 1982; 307: 1476-1480
        • Morrow GR
        • Asbury R
        • Hammon S
        • Dobkin P
        • Caruso L
        • Pandya K
        • et al.
        Comparing the effectiveness of behavioral treatment for chemotherapy-induced nausea and vomiting when administered by oncologists, oncology nurses, and clinical psychologists.
        Health Psychol. 1992; 11: 250-256
        • Burish TG
        • Vasterling JJ
        • Carey MP
        • Matt DA
        • Krozely MG.
        Posttreatment use of relaxation training by cancer patients.
        Hosp J. 1988; 4: 1-8
        • Burish TG
        • Jenkins RA.
        Effectiveness of biofeedback and relaxation training in reducing the side effects of cancer chemotherapy.
        Health Psychol. 1992; 11: 17-23
        • Lerman C
        • Rimer B
        • Blumberg B
        • Cristinzio S
        • Engstrom PF
        • MacElwee N
        • et al.
        Effects of coping style and relaxation on cancer chemotherapy side effects and emotional responses.
        Cancer Nurs. 1990; 13: 308-315
        • Burish TG
        • Lyles JN.
        Effectiveness of relaxation training in reducing the aversiveness of chemotherapy in the treatment of cancer.
        J Behav Ther Exp Psychiatry. 1979; 10: 357-361
        • Morrow GR.
        Effect of the cognitive hierarchy in the systematic desensitization treatment of anticipatory nausea in cancer patients: a component comparison with relaxation only, counseling, and no treatment.
        Cogn Ther Res. 1986; 10: 421-446
        • Redd WH
        • Andrykowski MA.
        Behavioral intervention in cancer treatment: controlling aversion reactions to chemotherapy.
        J Consult Clin Psychol. 1982; 50: 1018-1029
        • Giorlando S
        • Mascola R.
        The treatment of hyperemesis gravidarum with hypnotherapy.
        Am J Obstet Gynecol. 1957; 73: 444-447
        • Kroger W
        • DeLee S.
        The psychosomatic treatment of hyperemesis gravidarum by hypnosis.
        Am J Obstet Gynecol. 1946; 51: 544-552
        • Cotanch P
        • Hockenberry M
        • Herman S.
        Self-hypnosis as antiemetic therapy in children receiving chemotherapy.
        Oncol Nurs Forum. 1985; 12: 41-46
        • LaBaw W
        • Holton C
        • Tewell K
        • Eccles D.
        The use of self-hypnosis by children with cancer.
        Am J Clin Hypn. 1975; 17: 233-238
        • Zeltzer L
        • Kellerman J
        • Ellenberg L
        • Dash J.
        Hypnosis for reduction of vomiting associated with chemotherapy and disease in adolescents with cancer.
        J Adolesc Health Care. 1983; 4: 77-84
        • Kolko DJ
        • Rickard-Figueroa JL.
        Effects of video games on the adverse corollaries of chemotherapy in pediatric oncology patients: a single-case analysis.
        J Consult Clin Psychol. 1985; 53: 223-228
        • Redd WH
        • Jacobsen PB
        • Die-Trill M
        • Dermatis H
        • McEvoy M
        • Holland JC.
        Cognitive/attentional distraction in the control of conditioned nausea in pediatric cancer patients receiving chemotherapy.
        J Consult Clin Psychol. 1987; 55: 391-395
      1. Emesis in anti-cancer therapy. Mechanisms and treatment. Chapman and Hall Medical, London1993
        • Fallowfield LJ.
        Behavioural interventions and psychological aspects of care during chemotherapy.
        Eur J Cancer. 1992; 28A: S39-S41
        • Montgomery GH
        • Tomoyasu N
        • Bovbjerg DH
        • Andrykowski MA
        • Currie VE
        • Jacobsen PB
        • et al.
        Patients' pretreatment expectations of chemotherapy-related nausea are an independent predictor of anticipatory nausea.
        Ann Behav Med. 1998; 20: 104-109